Lagevrio

Watch this video featuring Colin Shepard, MD, CDC Liaison to ASPR, as he discusses Lagevrio (molnupiravir), an oral antiviral authorized for the treatment of mild to moderate COVID-19 for certain adults whom alternative COVID-19 treatment options are not clinically appropriate.

To learn more and view all resources for this video and other videos in the ASPR Outpatient COVID-19 Therapeutics Videos Series please visit: https://aspr.hhs.gov/COVID-19/Therape....

In addition, you can watch the playlist and/or each of the individual videos:

Overview: COVID-19 Therapeutics:    • Understanding COVID-19 Therapeutics f...  
Evusheld:    • Evusheld  
Paxlovid:    • Paxlovid  
Lagevrio (molnupiravir):    • Lagevrio  
Veklury® (remdesivir):    • Veklury (remdesivir)  
Bebtelovimab:    • Bebtelovimab  
COVID-19 Therapeutic Distribution:    • The U.S. Government’s Role to Help Di...